<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="38089">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02610647</url>
  </required_header>
  <id_info>
    <org_study_id>LOCAL/2014/ADKT-001</org_study_id>
    <secondary_id>2014-A01257-40</secondary_id>
    <nct_id>NCT02610647</nct_id>
  </id_info>
  <brief_title>Functional Significance of Complexity Measures in the Sensory-motor Behavior</brief_title>
  <acronym>NEURO COMP</acronym>
  <official_title>Functional Significance of Complexity Measures in the Sensory-motor Behavior: Are There Potential Clinical Applications?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to compare between groups the level of complexity of the
      estimated sensorimotor performance through multi-fractal (minmaxMF-DFA) exponents.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The secondary objectives of this study are to compare the level of complexity of the
      estimated sensorimotor performance using the(A) mono-fractal exhibitors (the αDFA values)
      and the (B) coefficient of variation (CV) between groups.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>July 2017</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>minmaxMF-DFA value during the tapping test</measure>
    <time_frame>Day 0</time_frame>
    <description>The level of complexity of the estimated sensorimotor performance as measured by the multi-fractal exponents.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Coefficient of variation</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>αDFA value during the tapping test</measure>
    <time_frame>Day 0</time_frame>
    <description>The level of complexity of the estimated sensorimotor performance as measured by the single-fractal exponent.</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects randomized to this group will have a tapping test with no sensory blocking.
Intervention: Tapping test</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wrist anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects randomized to this group will have an axillary block / regional anesthesia followed by a tapping test.
Intervention: Wrist anesthesia
Intervention: Tapping test</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wrist anesthesia, masked</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects randomized to this group will have an axillary block / regional anesthesia, will wear a blinding mask, and then will perform a tapping test.
Intervention: Wrist anesthesia
Intervention: Blinding mask
Intervention: Tapping test</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wrist anesthesia, helmet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects randomized to this group will have an axillary block / regional anesthesia, will wear an anti-noise helmet, and then will perform a tapping test.
Intervention: Wrist anesthesia
Intervention: Anti-noise helmet
Intervention: Tapping test</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wrist anesthesia, masked &amp; helmet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects randomized to this group will have an axillary block / regional anesthesia, will wear a blinding mask, will wear an anti-noise helmet, and then will perform a tapping test.
Intervention: Wrist anesthesia
Intervention: Blinding mask
Intervention: Anti-noise helmet
Intervention: Tapping test</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Wrist anesthesia</intervention_name>
    <description>Prior to the tapping test, regional anesthesia is performed in the form of sensory blocks distal to the wrist: injection of ropivacaine 7.5mg / ml is carried out successively in contact with three nerves (ulnar, median and radial) with a volume of 2 ml for nerve, for a total of 45mg.</description>
    <arm_group_label>Wrist anesthesia</arm_group_label>
    <arm_group_label>Wrist anesthesia, masked</arm_group_label>
    <arm_group_label>Wrist anesthesia, helmet</arm_group_label>
    <arm_group_label>Wrist anesthesia, masked &amp; helmet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blinding mask</intervention_name>
    <description>Patients will don a mask that prevents them from seeing during the tapping test.</description>
    <arm_group_label>Wrist anesthesia, masked</arm_group_label>
    <arm_group_label>Wrist anesthesia, masked &amp; helmet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Anti-noise helmet</intervention_name>
    <description>Patients will don a helmet that prevents them from hearing during the tapping test.</description>
    <arm_group_label>Wrist anesthesia, helmet</arm_group_label>
    <arm_group_label>Wrist anesthesia, masked &amp; helmet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Tapping test</intervention_name>
    <description>Subjects will be placed at a table in a sitting position where they will perform a rhythmic finger tapping test. The seat height is adjusted so that the front dominant arm rests comfortably on the table. Subjects will be equipped with headphones to receive auditory signals during a first synchronized phase of tapping.
After the last auditory signal, participants will continue the tapping task by themselves as directed: &quot;after the metronome stops,continue tapping the prescribed tempo as accurately and consistently as possible throughout the test.&quot; The movements of the index finger will be measured by a single-axis accelerometer (15 × 15 mm) attached to the nail.</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Wrist anesthesia</arm_group_label>
    <arm_group_label>Wrist anesthesia, masked</arm_group_label>
    <arm_group_label>Wrist anesthesia, helmet</arm_group_label>
    <arm_group_label>Wrist anesthesia, masked &amp; helmet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient must have given his/her informed and signed consent

          -  The patient must be insured or beneficiary of a health insurance plan

          -  The subject does not practice music intensively (&lt;1h / day on average)

        Exclusion Criteria:

          -  The patient is participating in another study

          -  The patient is in an exclusion period determined by a previous study

          -  The patient is under judicial protection, or under guardianship

          -  The patient refuses to sign the consent

          -  It is impossible to correctly inform the patient

          -  The patient is pregnant, parturient, or breastfeeding

          -  The subject regularly practices music

          -  The subject is suffering from a neurodegenerative disease of the central or
             peripheral nervous system which may affect the sensorimotor control of rhythmic
             movements of the upper limb

          -  The subject has had a recent trauma of the upper limb

          -  The subject is suffering from uncorrected visual and hearing impairment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kjerstin Torre, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Centre Hospitalier Universitaire de Nîmes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Arnaud Dupeyron, MD, PhD</last_name>
    <phone>+33.(0)4.66.68.34.59</phone>
    <email>arnaud.dupeyron@chu-nimes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carey Suehs, PhD</last_name>
    <phone>+33.(0)4.66.68.67.88</phone>
    <email>carey.suehs@chu-nimes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Laboratoire Movement to Health (M2H), Euromov, Université Montpellier 1</name>
      <address>
        <city>Montpellier</city>
        <zip>34090</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Kjerstin Torre, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stéphane Perrey, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Montpellier - Hôpital Lapeyronie</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Isabelle Laffont, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU de Nîmes - Hôpital Universitaire Carémeau</name>
      <address>
        <city>Nîmes Cedex 09</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Arnaud Dupeyron, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric Viel, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 14, 2016</lastchanged_date>
  <firstreceived_date>November 18, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
